These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6527237)

  • 21. [Cinoxacin in infections of the lower urinary tract].
    Montefiore F; Bassi G; Laguzzi E; Mele L
    Minerva Med; 1988 Apr; 79(4):323-4. PubMed ID: 3368114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of cinoxacin in humans.
    Black HR; Israel KS; Wolen RL; Brier GL; Obermeyer BD; Ziege EA; Wolny JD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):165-70. PubMed ID: 426511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein binding of quinolonecarboxylic acids. II. Spectral changes on the interaction of cinoxacin, nalidixic acid and pipemidic acid with human and rat albumins.
    Izumi T; Nagayama T; Kitagawa T
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):746-52. PubMed ID: 2752488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of hydrochlorothiazide in fasted and nonfasted subjects: a comparison of plasma level and urinary excretion methods.
    Barbhaiya RH; Craig WA; Corrick-West HP; Welling PG
    J Pharm Sci; 1982 Feb; 71(2):245-8. PubMed ID: 7062255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of cinoxacin-induced DNA fragmentation and mutations in the rat granuloma pouch.
    Pino A; Maura A; Grillo P
    Environ Mol Mutagen; 1989; 13(2):112-5. PubMed ID: 2917551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol induces hyper and hypoglycemia in both fasted and nonfasted rats dependent on the ambient temperature.
    Souza ML; Masur J
    Pharmacol Biochem Behav; 1984 May; 20(5):649-52. PubMed ID: 6739510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term cinoxacin therapy for chronic complicated urinary tract infection].
    Ueyama H
    Hinyokika Kiyo; 1984 Jun; 30(6):849-55. PubMed ID: 6485978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic prophylaxis of urinary tract infections in diabetic patients].
    Di Mauro M; Leonardi R; La Bella G; Iani P
    Minerva Med; 1990; 81(1-2):69-74. PubMed ID: 2314619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low-dose cinoxacin therapy and placebo in the prevention of recurrent urinary tract infections.
    Scheckler WE; Burt RA; Paulson DF
    J Fam Pract; 1982 Nov; 15(5):901-4. PubMed ID: 6752331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-blind comparison of cinoxacin and nitrofurantoin in the treatment of urinary tract infection.
    Schneider RE
    Clin Ther; 1982; 4(5):390-4. PubMed ID: 7039840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals.
    Dawes CP; Kendall MJ; Welling PG
    Br J Clin Pharmacol; 1979 Mar; 7(3):299-302. PubMed ID: 427007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study on long-term cinoxacin therapy for outpatients with chronic complicated urinary tract infections].
    Matsumoto J; Yamasaki Y; Katoh M; Tada S
    Hinyokika Kiyo; 1985 May; 31(5):895-900. PubMed ID: 4050634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of immobilization stress on serum triglycerides, nonesterified fatty acids, and total cholesterol in male rats after dietary modifications.
    Hershock D; Vogel WH
    Life Sci; 1989; 45(2):157-65. PubMed ID: 2747424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection.
    Brumfitt W; Smith GW; Hamilton-Miller JM; Bax R
    J Antimicrob Chemother; 1985 Dec; 16(6):781-8. PubMed ID: 4093347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
    Bucy JG
    J Urol; 1981 Jun; 125(6):822-4. PubMed ID: 7017171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of alcohol following single low doses to fasted and nonfasted subjects.
    Welling PG; Lyons LL; Elliott R; Amidon GL
    J Clin Pharmacol; 1977 Apr; 17(4):199-206. PubMed ID: 849994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cinoxacin in normal volunteers and patients with impaired renal function.
    Ohkawa M; Sugata T; Sawaki M; Okasho A; Kuroda K; Yamada H
    J Antimicrob Chemother; 1981 Dec; 8(6):447-51. PubMed ID: 7333988
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative clinical study of the antibacterial activity of cinoxacin and norfloxacin in urinary tract infections].
    Pennisi M; Viscusi G; Salanitri G; Cammarata E; Gazzo G
    Minerva Urol Nefrol; 1987; 39(1):51-6. PubMed ID: 3616862
    [No Abstract]   [Full Text] [Related]  

  • 40. Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy.
    Cox CE; Simmons JR
    South Med J; 1982 May; 75(5):549-50. PubMed ID: 7043747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.